Thunderbolt acquires rights to BAFF/APRIL dual antagonist programme
25 May 2016 | By Victoria White, Digital Content Producer
Thunderbolt is the first company established by Vitesse Biologics, a unique collaboration model formed by Baxalta, Mayo Clinic and VPD...